U.S. Wireless Telecom Stock News

NYSE:GOLD
NYSE:GOLDRetail Distributors

Assessing Gold.com (GOLD) Valuation After Board Changes And New Commodities Expertise

Gold.com (GOLD) drew investor attention after appointing Juan Sartori to its Board of Directors and announcing the retirement of longtime director Beverley Lepine, a governance shift linked to experience in commodities and alternative assets. See our latest analysis for Gold.com. The Board change comes as Gold.com trades at a share price of $47.89, with a 46.45% 90 day share price return and a 71.11% 1 year total shareholder return. This suggests recent momentum has been strong despite a...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

A Look At EyePoint Pharmaceuticals (EYPT) Valuation Following Recent Mixed Share Price Performance

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...
NYSE:MSGE
NYSE:MSGEEntertainment

A Look At Madison Square Garden Entertainment (MSGE) Valuation After The Appointment Of New Chief Legal Officer

Madison Square Garden Entertainment (MSGE) has drawn fresh investor attention after appointing Allen Lo as Executive Vice President and Chief Legal Officer, a move that more closely connects the live entertainment group to deep technology and media legal expertise. See our latest analysis for Madison Square Garden Entertainment. The appointment of Allen Lo comes at a time when MSGE’s share price has pulled back in the short term. The 1 month share price return shows an 8% decline, but the 90...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Is Corvus Pharmaceuticals’ Expanded US$200 Million ATM Facility Reframing Its Funding Story for CRVS?

In March 2026, Corvus Pharmaceuticals filed a universal shelf registration and expanded its at-the-market equity program with Jefferies to US$200 million, adding flexibility to issue common and preferred stock, debt, warrants and units to support ongoing operations. This expanded financing capacity sits alongside a sharp reduction in full-year 2025 net loss to US$15.28 million and continued clinical progress for lead candidate soquelitinib, together reshaping how investors may view the...
NasdaqGS:TCOM
NasdaqGS:TCOMHospitality

Is It Time To Revisit Trip.com Group (TCOM) After A 29.6% Year To Date Decline

Wondering if Trip.com Group is starting to look like value or a value trap at around US$52 a share? This article breaks down what the current price might be implying. The stock is around US$52.41, with a 1 week return of a 1.4% decline, a 30 day return of a 3.7% decline, and a year to date return of a 29.6% decline, alongside a 1 year return of a 20.7% decline and gains of 38.2% and 32.5% over 3 and 5 years respectively. Recent coverage of Trip.com Group has focused on how the share price...
NYSE:PSN
NYSE:PSNProfessional Services

A Look At Parsons (PSN) Valuation After Recent Share Price Swings

Parsons (PSN) has attracted attention after recent share price swings, with the stock up about 3% over the past day but showing declines over the past week, month and past 3 months. See our latest analysis for Parsons. That 3% one day share price gain comes after a weaker patch, with the 30 day share price return of 14.52% and year to date share price return of 12.91% both in negative territory, even as the 3 year total shareholder return of 29.74% shows a stronger longer term picture. If...
NYSE:TME
NYSE:TMEEntertainment

Tencent Music Entertainment Group (NYSE:TME) Earnings Highlight 34.1% Net Margin Supporting Bullish Narratives

Tencent Music Entertainment Group (NYSE:TME) just put fresh numbers on the board for FY 2025, with third quarter revenue of C¥8.5b and basic EPS of C¥1.40, set against the backdrop of trailing twelve month revenue of C¥31.7b and EPS of C¥7.05. Over recent quarters, revenue has moved from C¥7.0b in Q3 2024 to C¥7.5b in Q4 2024, C¥7.4b in Q1 2025, C¥8.4b in Q2 2025 and now C¥8.5b in Q3 2025. Quarterly EPS tracked from C¥1.02 to C¥1.27, C¥2.81, C¥1.57 and C¥1.40 over the same stretch. For...
NYSE:DOC
NYSE:DOCHealth Care REITs

Is It Time To Reconsider Healthpeak Properties (DOC) After Recent Share Price Recovery?

If you are wondering whether Healthpeak Properties is attractively priced or not, its current share price of US$17.65 only tells part of the story. The stock has returned 1.4% over the last week, 5.7% over the last month, and 9.0% year to date, while the 1 year return sits at a 7.6% decline and the 5 year return at a 27.1% decline. These mixed returns sit against a backdrop where Healthpeak Properties is part of the Health Care REITs space, a segment many investors watch for income and...
NasdaqGS:WAY
NasdaqGS:WAYHealthcare Services

Did Waystar’s Expanded Google Gemini Integration Just Shift Waystar Holding's (WAY) AI-Driven Investment Narrative?

On 5 March 2026, Waystar announced an expanded collaboration with Google Cloud to integrate Gemini models and data infrastructure more deeply into its AI-powered revenue cycle platform, aiming to scale automation across complex healthcare payment workflows. The next phase of this partnership focuses on agentic AI that combines financial and clinical intelligence from billions of transactions to reshape patient encounters and the full claims lifecycle. Next, we’ll examine how this deeper...
NYSE:PCOR
NYSE:PCORSoftware

Is It Time To Revisit Procore Technologies (PCOR) After Its Recent Share Price Pullback?

If you are wondering whether Procore Technologies at around US$59 a share is a bargain or just fairly priced, the valuation story is where things get interesting. The stock has recently shown mixed signals, with a 2.8% gain over the last 7 days and 12.7% over the last 30 days, while year to date it is down 15.8% and the 1 year return sits at a 14.0% decline. Recent attention on Procore has centered on its role in construction software and how investors are interpreting the stock's pullback...
NYSE:BXMT
NYSE:BXMTMortgage REITs

How Investors May Respond To Blackstone Mortgage Trust (BXMT) Dividend And Rising Bamco Stake

Blackstone Mortgage Trust, Inc. has declared a US$0.47 per‑share first‑quarter 2026 dividend on its Class A common stock, payable April 15, 2026 to shareholders of record on March 31, 2026. Separately, investment manager Bamco Inc. NY increased its stake to about 1.01% in the third quarter of 2026, underscoring growing institutional engagement with Blackstone Mortgage Trust’s commercial real estate lending platform. Next, we’ll examine how Bamco Inc. NY’s larger position could shape...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet Advertising Shift Puts Premium Quality Story And Investors To Test

Freshpet has permanently revised its dog food advertising to remove or clarify "human grade" claims following a review by the National Advertising Division. The changes come after a recent regulatory challenge that focused on how clearly the company described the quality standards of its pet food. The updated claims reflect Freshpet's decision to align its marketing more closely with industry advertising guidelines. For investors watching NasdaqGM:FRPT, the move comes at a time when the...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Assessing Exact Sciences (EXAS) Valuation After Recent Share Price Momentum And Tight Fair Value Gap

Exact Sciences stock snapshot Exact Sciences (EXAS) has drawn investor attention after recent share price moves, with the stock near US$103.94 and return figures over the past year and past 3 years standing out against its 5 year record. See our latest analysis for Exact Sciences. The recent move in Exact Sciences' share price to around US$103.94 comes after a strong 1 year total shareholder return of 131.39%. However, the 5 year total shareholder return shows a decline of 21.26%, indicating...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics Joins CRISPR Atlas Effort As Long Term Demand Test

10x Genomics (NasdaqGS:TXG) joined PerturbAI, NVIDIA, and the Allen Institute to help build and analyze what is being described as the world's largest in vivo CRISPR atlas. The project uses 10x Genomics' technology to connect genetic perturbations with cellular responses at scale, supporting causal genomics research. The new dataset is expected to be used in therapeutic discovery and is drawing attention from researchers and investors. For investors watching NasdaqGS:TXG, this scientific...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

Institutional Focus Grows As MakeMyTrip Expands Digital Travel Platform

MakeMyTrip (NasdaqGS:MMYT) is drawing increased market attention as institutional investors adjust their exposure to the stock. The company is expanding its digital travel platform, with recent activity focused on broadening services and reach across online travel segments. These developments are being closely watched by market participants assessing the company’s role in the wider global travel ecosystem. MakeMyTrip operates a digital travel platform that connects users with flights,...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Institutional Exit Tests Duolingo User Growth Story And Monetization Path

Baron Opportunity Fund has exited its position in Duolingo (NasdaqGS:DUOL) after the company highlighted slower user growth and a plan to prioritize daily active users over faster monetization. The exit follows Duolingo's decision to delay some monetization efforts in order to focus on engagement, which may affect near term bookings. Argus recently downgraded Duolingo, adding to the market reaction around the company’s user first growth approach. Duolingo shares trade at $104.36, with the...
NYSE:PEG
NYSE:PEGIntegrated Utilities

Is Public Service Enterprise Group (PEG) Fairly Priced After Recent Utilities Sector Interest?

To decide whether Public Service Enterprise Group is attractively priced, you need to know if the current share price lines up with what the business might reasonably be worth. The stock last closed at US$84.74, with returns of 1.8% over 7 days, a 1.9% decline over 30 days, 4.6% year to date, 6.5% over 1 year, 59.9% over 3 years, and 71.6% over 5 years. These performance figures can shape how you think about both upside potential and current risk. Recent news coverage has focused on Public...
NYSE:SYF
NYSE:SYFConsumer Finance

Synchrony Highlights Home Maintenance Cost Gap And Expands Financing Opportunities

Synchrony Financial released a national study highlighting a wide gap between what homeowners expect to pay for maintenance and the actual costs. The study points to economic pressures that are leading many homeowners to delay or cancel needed repairs and upgrades. In response, Synchrony is promoting financing tools, including its Project Card, as a way to help households manage these unplanned or larger home expenses. For investors watching NYSE:SYF, this move reflects how the company is...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Is It Time To Reassess Carvana (CVNA) After Its Volatile Multi Year Share Price Surge?

Investors may be wondering whether Carvana's share price still makes sense after a large increase, or if the stock has already reflected most of the positive developments. Carvana has seen a very large 3 year return and an 89.0% return over the last year, while the shares show a 1.3% decline over 7 days, an 8.2% decline over 30 days and a 21.4% decline year to date. Recent headlines have focused on Carvana as a high profile e-commerce auto retailer, with attention often centering on its...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

Is It Too Late To Consider TTM Technologies (TTMI) After A 347% One Year Surge?

TTM Technologies has caught the eye of many investors who are asking the same question you might be asking now: is the current share price offering good value, or are you arriving late? The stock recently closed at US$97.54, with returns of 1.2% over 7 days, 6.3% over 30 days, 38.1% year to date and 347.2% over the last year, while the 3 year and 5 year returns are both very large. Recent coverage has focused on how these strong returns have pushed TTM Technologies further onto investors'...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Sarah Robb O’Hagan Appointment Tests Peloton’s Connected Wellness Turnaround Narrative

Peloton Interactive (NasdaqGS:PTON) has appointed Sarah Robb O’Hagan as Chief Content and Member Development Officer. Her remit is to lead Peloton’s shift from a connected fitness model toward a broader connected wellness offering. The move targets deeper member engagement and a stronger content engine at the core of Peloton’s turnaround efforts. For investors watching Peloton’s turnaround, this leadership change arrives against a mixed share price backdrop. The stock trades at $4.13, with...
NYSE:AEO
NYSE:AEOSpecialty Retail

American Eagle Outfitters Upgrade Puts Valuation Gap And Margins In Focus

Analysts have recently raised their view on American Eagle Outfitters (NYSE:AEO) to a Strong Buy rating. The company now sits under a positive earnings outlook consensus, pointing to a shift in broader sentiment. The change in rating and outlook highlights growing attention on the retailer's business prospects. American Eagle Outfitters, the apparel and accessories retailer behind the American Eagle and Aerie brands, operates in a sector where consumer spending patterns and fashion trends...
NYSE:GD
NYSE:GDAerospace & Defense

Is It Too Late To Consider General Dynamics (GD) After A 36% One‑Year Rally?

Wondering if General Dynamics at around US$356 per share still offers value, or if most of the easy gains are already on the table. The stock's return profile, including 0.2% over the past week, 2.5% over the past month, 3.8% year to date and 35.8% over the last year, points to a company that has kept investors engaged through recent market cycles. Over the past three years, the share price return of 70.5% and 127.1% over five years provides important context for anyone trying to separate...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Huntington Bancshares Buybacks And Synergies Reframe Acquisition Integration Story

Huntington Bancshares (NasdaqGS:HBAN) reports progress on its Veritex integration, highlighting execution on recent acquisition activity. The bank cites strong retention of Cadence customers as it continues to combine acquired operations with its core franchise. Huntington accelerates its share repurchase program, with updated 2026 guidance and planned additional buybacks in 2027. The company is targeting about 5% of its shares to be retired by the end of next year and over US$500 million in...